Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 108851-108900 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03543098
STaR Trial: Multiple Ligament Knee Injuries
NA
Active, not recruiting
690 participants
Started: Jul 31, 2018 · Completed: Jun 30, 2027
2 conditions
31 sponsors
1 location
NCT03504956
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
NA
Recruiting
150 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03504241
Tolerance by Engaging Antigen During Cellular Homeostasis
PHASE1
Active, not recruiting
8 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2029
3 conditions
4 sponsors
1 location
NCT03538639
Vascular Disease Discovery Protocol
N/A
Recruiting
1,000 participants
Started: Jul 30, 2018 · Completed: May 15, 2037
3 conditions
1 sponsor
1 location
NCT03412812
A Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain Metastases
NA
Active, not recruiting
13 participants
Started: Jul 30, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04194138
Complex Adult Deformity Surgery (CADS)
N/A
Recruiting
500 participants
Started: Jul 30, 2018 · Completed: Jul 31, 2032
4 conditions
4 sponsors
19 locations
NCT03854071
Development of Novel Physiological CMR Methods in Health and Disease
NA
Recruiting
135 participants
Started: Jul 30, 2018 · Completed: Jan 1, 2031
4 conditions
1 sponsor
1 location
NCT04191551
The GAstric Precancerous Conditions Study
N/A
Recruiting
600 participants
Started: Jul 30, 2018 · Completed: Jun 30, 2028
4 conditions
1 sponsor
1 location
NCT03522064
Bipolar Androgen Therapy + Carboplatin in mCRPC
PHASE2
Recruiting
30 participants
Started: Jul 30, 2018 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT04862117
Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)
NA
Active, not recruiting
14 participants
Started: Jul 28, 2018 · Completed: Dec 8, 2026
1 condition
1 sponsor
4 locations
NCT02418832
Testis Needle Aspiration of Sperm in Men With Azoospermia
NA
Recruiting
150 participants
Started: Jul 28, 2018 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT03168516
Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants
PHASE3
Active, not recruiting
1,065 participants
Started: Jul 27, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
32 locations
NCT03630289
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
NA
Active, not recruiting
12 participants
Started: Jul 27, 2018 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT03716167
Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers Using Near Infrared Laser Therapy
NA
Recruiting
20 participants
Started: Jul 27, 2018 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT03502668
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
PHASE1/PHASE2
Active, not recruiting
160 participants
Started: Jul 27, 2018 · Completed: Dec 1, 2025
1 condition
1 sponsor
29 locations
NCT03607422
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
PHASE3
Active, not recruiting
912 participants
Started: Jul 27, 2018 · Completed: Nov 4, 2025
1 condition
1 sponsor
196 locations
NCT03568058
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
PHASE1
Active, not recruiting
30 participants
Started: Jul 26, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03568630
Blood Markers of Early Pancreas Cancer
N/A
Recruiting
1,250 participants
Started: Jul 26, 2018 · Completed: Jul 31, 2028
6 conditions
4 sponsors
1 location
NCT03908788
Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy
NA
Active, not recruiting
130 participants
Started: Jul 26, 2018 · Completed: Oct 31, 2025
1 condition
1 sponsor
2 locations
NCT03500991
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
PHASE1
Active, not recruiting
10 participants
Started: Jul 26, 2018 · Completed: Jul 26, 2039
9 conditions
1 sponsor
1 location
NCT03589846
Muscle Stimulation During DISE
NA
Enrolling by invitation
60 participants
Started: Jul 26, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03561740
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients
PHASE3
Recruiting
794 participants
Started: Jul 25, 2018 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03597165
Incidental Genomics
NA
Active, not recruiting
289 participants
Started: Jul 25, 2018 · Completed: Oct 1, 2027
1 condition
1 sponsor
3 locations
NCT03285789
Dyslexics' Visual Attention Field
NA
Active, not recruiting
1,460 participants
Started: Jul 25, 2018 · Completed: Oct 21, 2026
1 condition
1 sponsor
1 location
NCT03336606
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
PHASE1
Active, not recruiting
35 participants
Started: Jul 25, 2018 · Completed: Dec 1, 2026
5 conditions
3 sponsors
1 location
NCT03654131
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
PHASE2
Active, not recruiting
100 participants
Started: Jul 25, 2018 · Completed: Dec 3, 2029
2 conditions
1 sponsor
1 location
NCT03301038
Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
PHASE2
Recruiting
60 participants
Started: Jul 25, 2018 · Completed: Dec 31, 2030
6 conditions
2 sponsors
1 location
NCT03593720
Glans Size in Hypospadias Compared to Normal
N/A
Enrolling by invitation
90 participants
Started: Jul 25, 2018 · Completed: Dec 29, 2025
2 conditions
1 sponsor
1 location
NCT03143322
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
NA
Active, not recruiting
168 participants
Started: Jul 24, 2018 · Completed: Jul 22, 2027
4 conditions
1 sponsor
28 locations
NCT03480776
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
PHASE2
Active, not recruiting
117 participants
Started: Jul 24, 2018 · Completed: Sep 15, 2026
1 condition
2 sponsors
17 locations
NCT03389100
Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
PHASE2
Enrolling by invitation
600 participants
Started: Jul 24, 2018 · Completed: Jun 30, 2026
2 conditions
3 sponsors
1 location
NCT03573700
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
PHASE1/PHASE2
Active, not recruiting
24 participants
Started: Jul 24, 2018 · Completed: Jul 1, 2025
2 conditions
1 sponsor
1 location
NCT03595917
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
PHASE1
Recruiting
40 participants
Started: Jul 24, 2018 · Completed: Nov 1, 2026
3 conditions
2 sponsors
4 locations
NCT03127904
Vein Fitness System vs Compressive Therapy for Venous Ulcers: a Bayesian Adaptive Trial
NA
Recruiting
120 participants
Started: Jul 24, 2018 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT03388593
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.
PHASE3
Recruiting
1,600 participants
Started: Jul 23, 2018 · Completed: Feb 28, 2026
1 condition
1 sponsor
65 locations
NCT03400215
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer
NA
Recruiting
135 participants
Started: Jul 23, 2018 · Completed: Apr 17, 2025
1 condition
1 sponsor
1 location
NCT03792867
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
NA
Active, not recruiting
5 participants
Started: Jul 23, 2018 · Completed: Mar 31, 2024
1 condition
1 sponsor
1 location
NCT06381232
Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population
N/A
Recruiting
20,000 participants
Started: Jul 23, 2018 · Completed: Jul 23, 2028
2 conditions
1 sponsor
1 location
NCT03492177
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
PHASE2
Active, not recruiting
63 participants
Started: Jul 23, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
34 locations
NCT03286868
Balancing Kinematically Aligned Total Knee Replacements During Total Primary Knee Arthroplasty Using Verasense
NA
Recruiting
60 participants
Started: Jul 23, 2018 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT03686748
Two Point Discrimination
EARLY_PHASE1
Active, not recruiting
60 participants
Started: Jul 21, 2018 · Completed: Jul 16, 2027
6 conditions
1 sponsor
1 location
NCT03566797
Secondary Sclerosis Cholangitis Prospective
N/A
Recruiting
380 participants
Started: Jul 20, 2018 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03439735
Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC
PHASE2
Active, not recruiting
45 participants
Started: Jul 20, 2018 · Completed: Nov 1, 2026
1 condition
3 sponsors
1 location
NCT03237780
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
PHASE2
Active, not recruiting
72 participants
Started: Jul 20, 2018 · Completed: Jun 30, 2027
24 conditions
1 sponsor
21 locations
NCT03354390
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
PHASE1
Active, not recruiting
17 participants
Started: Jul 20, 2018 · Completed: Mar 3, 2026
1 condition
2 sponsors
1 location
NCT03503630
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma
PHASE2
Active, not recruiting
44 participants
Started: Jul 20, 2018 · Completed: Jul 2, 2024
1 condition
3 sponsors
3 locations
NCT03494322
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
PHASE2
Active, not recruiting
130 participants
Started: Jul 20, 2018 · Completed: Oct 31, 2024
2 conditions
2 sponsors
1 location
NCT03521154
A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)
PHASE3
Active, not recruiting
216 participants
Started: Jul 19, 2018 · Completed: Apr 13, 2027
1 condition
1 sponsor
118 locations
NCT03505762
Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
PHASE2
Active, not recruiting
80 participants
Started: Jul 19, 2018 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT03727633
Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion
PHASE2
Recruiting
53 participants
Started: Jul 19, 2018 · Completed: Jan 18, 2026
1 condition
2 sponsors
4 locations
Previous
1
More pages
2175
2176
2177
2178
2179
2180
2181
More pages
2369
Next